Taiwanese Journal of Obstetrics and Gynecology
Volume 47, Issue 2 , Pages 141-150 , June 2008

Syndromes, Disorders and Maternal Risk Factors Associated with Neural Tube Defects (IV)

  • Chih-Ping Chen

      Affiliations

    • Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan
    • Department of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan
    • Department of Biotechnology, Asia University, Taipei, Taiwan
    • School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taipei, Taiwan
    • Institute of Clinical and Community Health Nursing, National Yang-Ming University, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Chih-Ping Chen, Department of Obstetrics and Gynecology, Mackay Memorial Hospital, 92, Section 2, Chung-Shan North Road, Taipei, Taiwan

,Accepted 17 April 2008.

References 

  1. Wu YW , Croen LA , Henning L , Najjar DV , Schembri M , Croughan MS . Potential association between infertility and spinal neural tube defects in offspring . Birth Defects Res A Clin Mol Teratol . 2006;76:718–722
  2. Bánhidy F , Acs N , Czeizel AE . Ovarian cysts, clomiphene therapy, and the risk of neural tube defects . Int J Gynaecol Obstet . 2008;100:86–88
  3. Lancaster PAL . Congenital malformations after in-vitro fertilisation . Lancet . 1987;330:1392–1393
  4. Cornel MC , Ten Kate LP , Dukes MNG , et al.   Ovulation induction and neural tube defects . Lancet . 1989;333:1386
  5. Cornel MC , Ten Kate LP , Te Meerman GJ . Ovulation induction, in-vitro fertilisation, and neural tube defects . Lancet . 1989;334:1530
  6. Cuckle HS , Wald NJ . Ovulation induction and neural tube defects . Lancet . 1989;334:1281
  7. Czeizel AE . Ovulation induction and neural tube defects . Lancet . 1989;334:167
  8. Robert E , Pradat E , Laumon B . Ovulation induction and neural tube defects: a registry study . Reprod Toxicol . 1991;5:83–84
  9. Medveczky E , Puhó E , Czeizel EA . The use of drugs in mothers of offspring with neural-tube defects . Pharmacoepidemiol Drug Saf . 2004;13:443–455
  10. Mills JL , Simpson JL , Rhoads GG , et al.   Risk of neural tube defects in relation to maternal fertility and fertility drug use . Lancet . 1990;336:103–104
  11. Van Loon K , Besseghir K , Eshkol A . Neural tube defects after infertility treatment: a review . Fertil Steril . 1992;58:875–884
  12. Greenland S , Ackerman DL . Clomiphene citrate and neural tube defects: a pooled analysis of controlled epidemiologic studies and recommendations for future studies . Fertil Steril . 1995;64:936–941
  13. Källén B , Olausson PO , Nygren KG . Neonatal outcome in pregnancies from ovarian stimulation . Obstet Gynecol . 2002;100:414–419
  14. Hansen M , Kurinczuk JJ , Bower C , Webb S . The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization . N Engl J Med . 2002;346:725–730
  15. Kurinczuk JJ , Hansen M , Bower C . The risk of birth defects in children born after assisted reproductive technologies . Curr Opin Obstet Gynecol . 2004;16:201–209
  16. Källén B , Finnström O , Nygren KG , Olausson PO . In vitro fertilization (IVF) in Sweden: risk for congenital malformations after different IVF methods . Birth Defects Res A Clin Mol Teratol . 2005;73:162–169
  17. Olson CK, Keppler-Noreuil KM, Romitti PA, Budelier WT, Ryan G, Sparks AE, et al. In vitro fertilization is associated with an increase in major birth defects . Fertil Steril . 2005;84:1308–1315
  18. MRC Vitamin Study Research Group  . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study . Lancet . 1991;338:131–137
  19. Czeizel AE , Dudás I . Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation . N Engl J Med . 1992;327:1832–1835
  20. Czeizel AE . Folic acid and prevention of birth defects . JAMA . 1996;275:1635–1666
  21. Hall JG , Solehdin F . Genetics of neural tube defects . Ment Retard Dev Disabil Res Rev . 1998;4:269–281
  22. Hibbard BM . The role of folic acid in pregnancy; with particular reference to anaemia, abruption and abortion . J Obstet Gynaecol Br Commonw . 1964;71:529–542
  23. Hibbard ED , Smithells RW . Folic acid metabolism and human embryopathy . Lancet . 1965;285:1254
  24. Smithells RW , Sheppard S , Schorah CJ , et al.   Possible prevention of neural-tube defects by periconceptional vitamin supplementation . Lancet . 1980;315:339–340
  25. Laurence KM , James N , Miller MH , Tennant GB , Campbell H . Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects . Br Med J (Clin Res Ed) . 1981;282:1509–1511
  26. Mulinare J , Cordero JF , Erickson JD , Berry RJ . Periconceptional use of multivitamins and the occurrence of neural tube defects . JAMA . 1988;260:3141–3145
  27. Bower C , Stanley FJ . Dietary folate as a risk factor for neuraltube defects: evidence from a case-control study in Western Australia . Med J Aust . 1989;150:613–619
  28. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects . JAMA . 1989;262:2847–2852
  29. Centers for Disease Control and Prevention  . Use of folic acid for prevention of spina bifida and other neural tube defects: 1983–1991 . MMWR Morb Mortal Wkly Rep . 1991;40:513–516
  30. Centers for Disease Control and Prevention  . Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects . MMWR Recomm Rep . 1992;41:1–7
  31. US Food and Drug Administration  . Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid . Fed Regist . 1996;61:8781–8797
  32. Werler MM , Shapiro S , Mitchell AA . Periconceptional folic acid exposure and risk of occurrent neural tube defects . JAMA . 1993;269:1257–1261
  33. Shaw GM , Schaffer D , Velie EM , Morland K , Harris JA . Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects . Epidemiology . 1995;6:219–226
  34. Berry RJ , Li Z , Erickson JD , et al.   Prevention of neural-tube defects with folic acid in China . N Engl J Med . 1999;341:1485–1490
  35. Honein MA , Paulozzi LJ , Mathews TJ , Erickson JD , Wong LY . Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects . JAMA . 2001;285:2981–2986
  36. Erickson JD . Folic acid and prevention of spina bifida and anencephaly: 10 years after the U.S. Public Health Service recommendation . MMWR Recomm Rep . 2002;51:1–3
  37. Persad VL , Van den Hof MC , Dubé JM , Zimmer P . Incidence of open neural tube defects in Nova Scotia after folic acid fortification . CMAJ . 2002;167:241–245
  38. Ray JG , Meier C , Vermeulen MJ , Boss S , Wyatt PR , Cole DE . Association of neural tube defects and folic acid food fortification in Canada . Lancet . 2002;360:2047–2048
  39. Castilla EE , Orioli IM , López-Camelo JS , Dutra Mda G , Nazer-Herrera J  Latin American Collaborative Study of Congenital Malformations (ECLAMC) . Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America . Am J Med Genet A . 2003;123:123–128
  40. De Wals P , Rusen ID , Lee NS , Morin P , Niyonsenga T . Trend in prevalence of neural tube defects in Quebec . Birth Defects Res A Clin Mol Teratol . 2003;67:919–923
  41. De Wals P , Tairou F , Van Allen MI , et al.   Reduction in neural-tube defects after folic acid fortification in Canada . N Engl J Med . 2007;357:135–142
  42. Centers for Disease Control and Prevention  . Spina bifida and anencephaly before and after folic acid mandate: United States, 1995–1996 and 1999–2000 . MMWR Morb Mortal Wkly Rep . 2004;53:362–365
  43. Chen LT , Rivera MA . The Costa Rican experience: reduction of neural tube defects following food fortification programs . Nutr Rev . 2004;62:S40–S43
  44. Mills JL , Signore C . Neural tube defect rates before and after food fortification with folic acid . Birth Defects Res A Clin Mol Teratol . 2004;70:844–845
  45. López-Camelo JS , Orioli IM , da Graça Dutra M , et al.   Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile . Am J Med Genet A . 2005;135:120–125
  46. Toriello HV , Professional Practice and Guidelines Committee  , American College of Medical Genetics  . Folic acid and neural tube defects . Genet Med . 2005;7:283–284
  47. Bayston R , Russell A , Wald NJ , Hoffbrand AV . Folic acid fortification and cancer risk . Lancet . 2007;370:2004
  48. Johnston RB . Will increasing folic acid in fortified grain products further reduce neural tube defects without causing harm?: consideration of the evidence . Pediatr Res . 2008;63:2–8
  49. Brouwer I , Verhoef P . Folic acid fortification: is masking of vitamin B-12 deficiency what we should really worry about? . Am J Clin Nutr . 2007;86:897–898
  50. Kim YI . Folic acid fortification and supplementation: good for some but not so good for others . Nutr Rev . 2007;65:504–511
  51. Smith AD . Folic acid fortification: the good, the bad, and the puzzle of vitamin B-12 . Am J Clin Nutr . 2007;85:3–5
  52. Solomons NW . Food fortification with folic acid: has the other shoe dropped? . Nutr Rev . 2007;65:512–515
  53. Smith AD , Kim YI , Refsum H . Is folic acid good for everyone? . Am J Clin Nutr . 2008;87:517–533
  54. Kirke PN , Molloy AM , Daly LE , Burke H , Weir DG , Scott JM . Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects . Q J Med . 1993;86:703–708
  55. Adams MJ , Khoury MJ , Scanlon KS , et al.   Elevated midtrimester serum methylmalonic acid levels as a risk factor for neural tube defects . Teratology . 1995;51:311–317
  56. van der Put NMJ , Thomas CM , Eskes TK , et al.   Altered folate and vitamin B12 metabolism in families with spina bifida offspring . QJM . 1997;90:505–510
  57. Wilson A , Platt R , Wu Q , et al.   A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida . Mol Genet Metab . 1999;67:317–323
  58. Afman LA , van der Put NMJ , Thomas CM , Trijbels JM , Blom HJ . Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects . QJM . 2001;94:159–166
  59. Ray JG , Blom HJ . Vitamin B12 insufficiency and the risk of fetal neural tube defects . QJM . 2003;96:289–295
  60. Suarez L , Hendricks K , Felkner M , Gunter E . Maternal serum B12 levels and risk for neural tube defects in a TexasMexico border population . Ann Epidemiol . 2003;13:81–88
  61. Groenen PM , van Rooij IA , Peer PG , Gooskens RH , Zielhuis GA , Steegers-Theunissen RP . Marginal maternal vitamin B12 status increases the risk of offspring with spina bifida . Am J Obstet Gynecol . 2004;191:11–17
  62. Gaber KR , Farag MK , Soliman SE , El-Bassyouni HT , ElKamah G . Maternal vitamin B12 and the risk of fetal neural tube defects in Egyptian patients . Clin Lab . 2007;53:69–75
  63. Ray JG , Wyatt PR , Thompson MD , et al.   Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population . Epidemiology . 2007;18:362–366
  64. Ray JG , Goodman J , O'Mahoney PR , Mamdani MM , Jiang D . High rate of maternal vitamin B12 deficiency nearly a decade after Canadian folic acid flour fortification . QJM . 2008;
  65. Beaudin AE , Stover PJ . Folate-mediated one-carbon metabolism and neural tube defects: balancing genome synthesis and gene expression . Birth Defects Res C Embryo Today . 2007;81:183–203
  66. Cabrera RM , Hill DS , Etheredge AJ , Finnell RH . Investigations into the etiology of neural tube defects . Birth Defects Res C Embryo Today . 2004;72:330–344
  67. Boyles AL , Hammock P , Speer MC . Candidate gene analysis in human neural tube defects . Am J Med Genet C Semin Med Genet . 2005;135:9–23
  68. Blom HJ , Shaw GM , den Heijer M , Finnell RH . Neural tube defects and folate: case far from closed . Nat Rev Neurosci . 2006;7:724–731
  69. De Marco P , Merello E , Mascelli S , Capra V . Current perspectives on the genetic causes of neural tube defects . Neurogenetics . 2006;7:201–221
  70. Padmanabhan R . Etiology, pathogenesis and prevention of neural tube defects . Congenit Anom (Kyoto) . 2006;46:55–67
  71. van der Linden IJM , Afman LA , Heil SG , Blom HJ . Genetic variation in genes of folate metabolism and neural-tube defect risk . Proc Nutr Soc . 2006;65:204–215
  72. Finnell RH , Mitchell LE . Neural tube defects . In:  Rimoin DL ,  Connor JM ,  Pyeritz RE ,  Korf BR editor. Emery and Rimoin's Principles and Practice of Medical Genetics . 5th edition. Philadelphia: Churchill Livingstone Elsevier; 2007;p. 2648–2660
  73. Kibar Z , Capra V , Gros P . Toward understanding the genetic basis of neural tube defects . Clin Genet . 2007;71:295–310
  74. Barber RC , Shaw GM , Lammer EJ , et al.   Lack of association between mutations in the folate receptor-alpha gene and spina bifida . Am J Med Genet . 1998;76:310–317
  75. Heil SG , van der Put NMJ , Trijbels FJ , Gabreëls FJ , Blom HJ . Molecular genetic analysis of human folate receptors in neural tube defects . Eur J Hum Genet . 1999;7:393–396
  76. O'Leary VB , Mills JL , Kirke PN , et al.   Analysis of the human folate receptor beta gene for an association with neural tube defects . Mol Genet Metab . 2003;79:129–133
  77. Rothenberg SP, da Costa MP, Sequeira JM, Cracco J, Roberts JL, Weedon J, et al. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect . N Engl J Med . 2004;350:134–142
  78. Chango A , Emery-Fillon N , de Courcy GP , et al.   A polymorphism (80G → A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia . Mol Genet Metab . 2000;70:310–315
  79. Shaw GM , Lammer EJ , Zhu H , Baker MW , Neri E , Finnell RH . Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida . Am J Med Genet . 2002;108:1–6
  80. De Marco P , Calevo MG , Moroni A , et al.   Reduced folate carrier polymorphism (80A→G) and neural tube defects . Eur J Hum Genet . 2003;11:245–252
  81. Morin I, Devlin AM, Leclerc D, Sabbaghian N, Halsted CH, Finnell R, et al. Evaluation of genetic variants in the reduced folate carrier and in glutamate carboxypeptidase II for spina bifida risk . Mol Genet Metab . 2003;79:197–200
  82. Pei L, Zhu H, Ren A, Li Z, Hao L, Finnell RH, et al. Reduced folate carrier gene is a risk factor for neural tube defects in a Chinese population . Birth Defects Res A Clin Mol Teratol . 2005;73:430–433
  83. Whitehead AS , Gallagher P , Mills JL , et al.   A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects . QJM . 1995;88:763–766
  84. van der Put NMJ , Steegers-Theunissen RP , Frosst P , et al.   Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida . Lancet . 1995;346:1070–1071
  85. van der Put NMJ , Eskes TK , Blom HJ . Is the common 677C→T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis . QJM . 1997;90:111–115
  86. Ou CY , Stevenson RE , Brown VK , et al.   5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects . Am J Med Genet . 1996;63:610–614
  87. Christensen B , Arbour L , Tran P , Leclerc D , et al.   Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects . Am J Med Genet . 1999;84:151–157
  88. Stegmann K , Ziegler A , Ngo ET , et al.   Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects (NTD) . Am J Med Genet . 1999;87:23–29
  89. Botto LD , Yang Q . 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review . Am J Epidemiol . 2000;151:862–877
  90. Martínez de Villarreal LE , Delgado-Enciso I , Valdéz-Leal R , et al.   Folate levels and N(5), N(10)-methylenetetrahydrofolate reductase genotype (MTHFR) in mothers of offspring with neural tube defects: a case-control study . Arch Med Res . 2001;32:277–282
  91. Parle-McDermott A , Mills JL , Kirke PN , et al.   Analysis of the MTHFR 1298A→C and 677C→T polymorphisms as risk factors for neural tube defects . J Hum Genet . 2003;48:190–193
  92. Rampersaud E , Melvin EC , Siegel D , et al.   Updated investigations of the role of methylenetetrahydrofolate reductase in human neural tube defects . Clin Genet . 2003;63:210–214
  93. Volcik KA , Shaw GM , Lammer EJ , Zhu H , Finnell RH . Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects . Birth Defects Res A Clin Mol Teratol . 2003;67:154–157
  94. van der Put NMJ , Gabreëls F , Stevens EM , et al.   A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? . Am J Hum Genet . 1998;62:1044–1051
  95. Weisberg I , Tran P , Christensen B , Sibani S , Rozen R . A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity . Mol Genet Metab . 1998;64:169–172
  96. Friedman G , Goldschmidt N , Friedlander Y , et al.   A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations . J Nutr . 1999;129:1656–1661
  97. Chango A , Boisson F , Barbé F , et al.   The effect of 677C→T and 1298A→C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects . Br J Nutr . 2000;83:593–596
  98. Richter B , Stegmann K , Röper B , Böddeker I , Ngo ET , Koch MC . Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population . J Hum Genet . 2001;46:105–109
  99. Relton CL , Wilding CS , Laffling AJ , et al.   Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy . Mol Genet Metab . 2004;81:273–281
  100. De Marco P , Calevo MG , Moroni A , et al.   Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population . J Hum Genet . 2002;47:319–324
  101. Doolin MT , Barbaux S , McDonnell M , Hoess K , Whitehead AS , Mitchell LE . Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida . Am J Hum Genet . 2002;71:1222–1226
  102. Guéant-Rodriguez RM , Rendeli C , Namour B , et al.   Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans . Neurosci Lett . 2003;344:189–192
  103. Zhu H , Wicker NJ , Shaw GM , et al.   Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects . Mol Genet Metab . 2003;78:216–221
  104. Gos M , Sliwerska E , Szpecht-Potocka A . Mutation incidence in folate metabolism genes and regulatory genes in Polish families with neural tube defects . J Appl Genet . 2004;45:363–368
  105. van der Put NMJ , van der Molen EF , Kluijtmans LA , et al.   Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease . QJM . 1997;90:511–517
  106. Morrison K, Papapetrou C, Hol FA, Mariman EC, Lynch SA, Burn J, et al. Susceptibility to spina bifida; an association study of five candidate genes . Ann Hum Genet . 1998;62:379–396
  107. Lucock M , Daskalakis I , Briggs D , Yates Z , Levene M . Altered folate metabolism and disposition in mothers affected by a spina bifida pregnancy: influence of 677c→t methylenetetrahydrofolate reductase and 2756a→g methionine synthase genotypes . Mol Genet Metab . 2000;70:27–44
  108. Lucock M , Daskalakis I , Hinkins M , Yates Z . An examination of polymorphic genes and folate metabolism in mothers affected by a spina bifida pregnancy . Mol Genet Metab . 2001;73:322–332
  109. Pietrzyk JJ , Bik-Multanowski M , Sanak M , Twardowska M . Polymorphisms of the 5,10-methylenetetrahydrofolate and the methionine synthase reductase genes as independent risk factors for spina bifida . J Appl Genet . 2003;44:111–113
  110. O'Leary VB , Mills JL , Pangilinan F , et al.   Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association . Mol Genet Metab . 2005;85:220–227
  111. Boyles AL , Billups AV , Deak KL , et al.   Neural tube defects and folate pathway genes: family-based association tests of gene–gene and gene–environment interactions . Environ Health Perspect . 2006;114:1547–1552
  112. Hum DW , Bell AW , Rozen R , MacKenzie RE . Primary structure of a human trifunctional enzyme. Isolation of a cDNA encoding methylenetetrahydrofolate dehydrogenasemethenyltetrahydrofolate cyclohydrolase-formyltetrahydrofolate synthetase . J Biol Chem . 1988;263:15946–15950
  113. Hol FA , van der Put NMJ , Geurds MP , et al.   Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects . Clin Genet . 1998;53:119–125
  114. Brody LC , Conley M , Cox C , et al.   A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group . Am J Hum Genet . 2002;71:1207–1215
  115. Parle-McDermott A , Kirke PN , Mills JL , et al.   Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population . Eur J Hum Genet . 2006;14:768–772
  116. De Marco P, Merello E, Calevo MG, Mascelli S, Raso A, Cama A, et al. Evaluation of a methylenetetrahydrofolatedehydrogenase 1958G>A polymorphism for neural tube defect risk . J Hum Genet . 2006;51:98–103
  117. Heil SG , van der Put NMJ , Waas ET , den Heijer M , Trijbels FJM , Blom HJ . Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? . Mol Genet Metab . 2001;73:164–172
  118. Woeller CF , Anderson DD , Szebenyi DME , Stover PJ . Evidence for small ubiquitin-like modifier-dependent nuclear import of the thymidylate biosynthesis pathway . J Biol Chem . 2007;282:17623–17631
  119. Lim U , Peng K , Shane B , et al.   Polymorphisms in cytoplasmic serine hydroxymethyltransferase and methylenetetrahydrofolate reductase affect the risk of cardiovascular disease in men . J Nutr . 2005;135:1989–1994
  120. Horie N , Aiba H , Oguro K , Hojo H , Takeishi K . Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase . Cell Struct Funct . 1995;20:191–197
  121. Kawakami K , Omura K , Kanehira E , Watanabe Y . Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers . Anticancer Res . 1999;19:3249–3252
  122. Kawakami K , Salonga D , Park JM , et al.   Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression . Clin Cancer Res . 2001;7:4096–4101
  123. Trinh BN , Ong CN , Coetzee GA , Yu MC , Laird PW . Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels . Hum Genet . 2002;111:299–302
  124. Wilding CS, Relton CL, Sutton MJ, Jonas PA, Lynch SA, Tawn EJ, et al. Thymidylate synthase repeat polymorphisms and risk of neural tube defects in a population from the northern United Kingdom . Birth Defects Res A Clin Mol Teratol . 2004;70:483–485
  125. Brown KS , Kluijtmans LAJ , Young IS , et al.   The thymidylate synthase tandem repeat polymorphism is not associated with homocysteine concentrations in healthy young subjects . Hum Genet . 2004;114:182–185
  126. Ulrich CM , Bigler J , Velicer CM , Greene EA , Farin FM , Potter JD . Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene . Cancer Epidemiol Biomarkers Prev . 2000;9:1381–1385
  127. Volcik KA , Shaw GM , Zhu H , Lammer EJ , Laurent C , Finnell RH . Associations between polymorphisms within the thymidylate synthase gene and spina bifida . Birth Defects Res A Clin Mol Teratol . 2003;67:924–928
  128. Johnson WG , Stenroos ES , Spychala JR , Chatkupt S , Ming SX , Buyske S . New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? . Am J Med Genet A . 2004;124:339–345
  129. van der Linden IJM , Nguyen U , Heil SG , et al.   Variation and expression of dihydrofolate reductase (DHFR) in relation to spina bifida . Mol Genet Metab . 2007;91:98–103
  130. Parle-McDermott A , Pangilinan F , Mills JL , et al.   The 19-bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR) may decrease rather than increase risk for spina bifida in the Irish population . Am J Med Genet A . 2007;143:1174–1180
  131. Stanislawska-Sachadyn A , Brown KS , Mitchell LE , et al.   An insertion/deletion polymorphism of the dihydrofolate reductase (DHFR) gene is associated with serum and red blood cell folate concentrations in women . Hum Genet . 2008;123:289–295

PII: S1028-4559(08)60071-6

doi: 10.1016/S1028-4559(08)60071-6

Taiwanese Journal of Obstetrics and Gynecology
Volume 47, Issue 2 , Pages 141-150 , June 2008

Article Tools